JP2012509138A - 持続的分析物モニタリングのためのデバイス、システム、方法、およびツール - Google Patents
持続的分析物モニタリングのためのデバイス、システム、方法、およびツール Download PDFInfo
- Publication number
- JP2012509138A JP2012509138A JP2011537444A JP2011537444A JP2012509138A JP 2012509138 A JP2012509138 A JP 2012509138A JP 2011537444 A JP2011537444 A JP 2011537444A JP 2011537444 A JP2011537444 A JP 2011537444A JP 2012509138 A JP2012509138 A JP 2012509138A
- Authority
- JP
- Japan
- Prior art keywords
- sensing
- analyte
- glucose
- space
- electrode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 195
- 238000000034 method Methods 0.000 title claims description 35
- 238000012544 monitoring process Methods 0.000 title claims description 26
- 239000012530 fluid Substances 0.000 claims abstract description 111
- 238000000605 extraction Methods 0.000 claims abstract description 50
- 238000004891 communication Methods 0.000 claims abstract description 21
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 154
- 239000008103 glucose Substances 0.000 claims description 154
- 210000003722 extracellular fluid Anatomy 0.000 claims description 23
- 210000001519 tissue Anatomy 0.000 claims description 22
- 239000000758 substrate Substances 0.000 claims description 21
- 230000000149 penetrating effect Effects 0.000 claims description 20
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 17
- 210000003491 skin Anatomy 0.000 claims description 16
- 238000005259 measurement Methods 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 7
- 230000033001 locomotion Effects 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 210000000434 stratum corneum Anatomy 0.000 claims description 5
- 238000003780 insertion Methods 0.000 claims description 3
- 230000037431 insertion Effects 0.000 claims description 3
- 230000036284 oxygen consumption Effects 0.000 claims description 3
- 238000001727 in vivo Methods 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000001788 irregular Effects 0.000 claims 1
- 210000004369 blood Anatomy 0.000 description 28
- 239000008280 blood Substances 0.000 description 28
- 230000035945 sensitivity Effects 0.000 description 20
- 108090000790 Enzymes Proteins 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 14
- 206010012601 diabetes mellitus Diseases 0.000 description 14
- 229940088598 enzyme Drugs 0.000 description 14
- 238000012806 monitoring device Methods 0.000 description 14
- 238000009792 diffusion process Methods 0.000 description 11
- 235000019420 glucose oxidase Nutrition 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 108010015776 Glucose oxidase Proteins 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 239000004366 Glucose oxidase Substances 0.000 description 9
- 229940116332 glucose oxidase Drugs 0.000 description 9
- 230000000737 periodic effect Effects 0.000 description 8
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000004020 conductor Substances 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 229910021607 Silver chloride Inorganic materials 0.000 description 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000003914 insulin secretion Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000002085 persistent effect Effects 0.000 description 3
- 238000007639 printing Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 2
- -1 ferricyanides Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 150000004053 quinones Chemical class 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000007650 screen-printing Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 238000004082 amperometric method Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000003869 coulometry Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000779 depleting effect Effects 0.000 description 1
- 239000012502 diagnostic product Substances 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000006056 electrooxidation reaction Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 230000004190 glucose uptake Effects 0.000 description 1
- 238000007646 gravure printing Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000006362 insulin response pathway Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000007649 pad printing Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010405 reoxidation reaction Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000004092 self-diagnosis Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000003115 supporting electrolyte Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000037221 weight management Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
- A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
- A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
- A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Optics & Photonics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/275,145 US20090131778A1 (en) | 2006-03-28 | 2008-11-20 | Devices, systems, methods and tools for continuous glucose monitoring |
| US12/275,145 | 2008-11-20 | ||
| PCT/US2009/054338 WO2010059276A1 (en) | 2008-11-20 | 2009-08-19 | Devices, systems, methods and tools for continuous analyte monitoring |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012509138A true JP2012509138A (ja) | 2012-04-19 |
| JP2012509138A5 JP2012509138A5 (enExample) | 2012-09-27 |
Family
ID=42198433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011537444A Pending JP2012509138A (ja) | 2008-11-20 | 2009-08-19 | 持続的分析物モニタリングのためのデバイス、システム、方法、およびツール |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20090131778A1 (enExample) |
| EP (1) | EP2355704A4 (enExample) |
| JP (1) | JP2012509138A (enExample) |
| CA (1) | CA2743572A1 (enExample) |
| WO (1) | WO2010059276A1 (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021506391A (ja) * | 2017-12-22 | 2021-02-22 | ブリテル アクチエボラグ パブリークBrighter Ab (Publ) | 診断用皮膚パッチ |
| JP2022537341A (ja) * | 2019-06-17 | 2022-08-25 | バイオリンク インコーポレイテッド | 分析物選択センサおよび注入システムの機械的結合 |
| JP7141625B1 (ja) | 2021-09-17 | 2022-09-26 | リンテック株式会社 | マイクロニードルパッチ及びマイクロニードル構造体 |
| WO2024005192A1 (ja) * | 2022-06-30 | 2024-01-04 | コスメディ製薬株式会社 | グルコースセンサー用電極 |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1869414A4 (en) * | 2005-03-29 | 2010-07-28 | Arkal Medical Inc | DEVICES, SYSTEMS, METHODS, AND TOOLS FOR CONTINUOUS GLUCOSE MONITORING |
| US20100049021A1 (en) * | 2006-03-28 | 2010-02-25 | Jina Arvind N | Devices, systems, methods and tools for continuous analyte monitoring |
| KR101542549B1 (ko) | 2011-09-02 | 2015-08-06 | 산디아 코포레이션 | 바이오센싱 및 약물 전달을 위한 마이크로니들 어레이 |
| US9622691B2 (en) * | 2011-10-31 | 2017-04-18 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
| GB2500176A (en) * | 2012-03-06 | 2013-09-18 | Univ Swansea | Biological fluid monitoring device |
| USD698443S1 (en) * | 2013-01-07 | 2014-01-28 | Bayer Healthcare Llc | Monitoring system |
| US9933387B1 (en) | 2014-09-07 | 2018-04-03 | Biolinq, Inc. | Miniaturized sub-nanoampere sensitivity low-noise potentiostat system |
| US10092207B1 (en) | 2016-05-15 | 2018-10-09 | Biolinq, Inc. | Tissue-penetrating electrochemical sensor featuring a co-electrodeposited thin film comprised of polymer and bio-recognition element |
| FR3059886B1 (fr) * | 2016-12-09 | 2021-04-09 | Pk Paris | Dispositif de surveillance corporelle |
| US12109032B1 (en) | 2017-03-11 | 2024-10-08 | Biolinq Incorporated | Methods for achieving an isolated electrical interface between an anterior surface of a microneedle structure and a posterior surface of a support structure |
| US11045142B1 (en) | 2017-04-29 | 2021-06-29 | Biolinq, Inc. | Heterogeneous integration of silicon-fabricated solid microneedle sensors and CMOS circuitry |
| TWI653968B (zh) | 2017-11-20 | 2019-03-21 | 研能科技股份有限公司 | 血糖偵測裝置 |
| CN109655513B (zh) * | 2019-01-25 | 2023-10-17 | 天津大学 | 一种自校准葡萄糖连续监测系统及其制备方法 |
| WO2021016465A1 (en) * | 2019-07-23 | 2021-01-28 | The Regents Of The University Of California | Minimally invasive continuous analyte monitoring for closed-loop treatment applications |
| TWI735137B (zh) * | 2019-08-02 | 2021-08-01 | 華廣生技股份有限公司 | 生理訊號傳感裝置 |
| GB2608290B (en) | 2020-07-29 | 2023-07-26 | Biolinq Incorporated | Continuous analyte monitoring system with microneedle array |
| US11857344B2 (en) | 2021-05-08 | 2024-01-02 | Biolinq Incorporated | Fault detection for microneedle array based continuous analyte monitoring device |
| EP4658168A2 (en) | 2023-02-02 | 2025-12-10 | Biolinq, Inc. | Method for improved sensor sensitivity of a microneedle-based continuous analyte monitoring system |
| GB2632399A (en) * | 2023-07-31 | 2025-02-12 | Continental Automotive Tech Gmbh | A skin patch wearable biosensor for simultaneous monitoring of physiological parameters in interstitial fluid |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003038467A (ja) * | 2001-06-12 | 2003-02-12 | Lifescan Inc | 生物流体サンプリングおよび分析物測定の装置および方法 |
| US20060219576A1 (en) * | 2005-03-29 | 2006-10-05 | Jina Arvind N | Devices, Systems, Methods And Tools For Continuous Glucose Monitoring |
Family Cites Families (93)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3964482A (en) * | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
| US4018938A (en) * | 1975-06-30 | 1977-04-19 | International Business Machines Corporation | Fabrication of high aspect ratio masks |
| OA05448A (fr) * | 1975-10-16 | 1981-03-31 | Manufrance Manufacture Francai | Dispositif vaccinateur multipénétrant. |
| US4071020A (en) * | 1976-06-03 | 1978-01-31 | Xienta, Inc. | Apparatus and methods for performing in-vivo measurements of enzyme activity |
| US4165395A (en) * | 1977-06-30 | 1979-08-21 | International Business Machines Corporation | Process for forming a high aspect ratio structure by successive exposures with electron beam and actinic radiation |
| JPS5590931A (en) * | 1978-12-29 | 1980-07-10 | Canon Inc | Production of micro structure element array |
| US4320758A (en) * | 1979-05-07 | 1982-03-23 | Alza Corporation | Osmotically driven fluid dispenser |
| US4846950A (en) * | 1983-09-08 | 1989-07-11 | Montefiore Hospital Assn Of Western Pa | Cyclic controlled electrolysis apparatus |
| US4821733A (en) * | 1987-08-18 | 1989-04-18 | Dermal Systems International | Transdermal detection system |
| US5641504A (en) * | 1988-06-09 | 1997-06-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolinoleate |
| US5208147A (en) * | 1988-07-21 | 1993-05-04 | Radiometer A/S | Means for measuring a characteristic in a sample fluid |
| US5438984A (en) * | 1988-09-08 | 1995-08-08 | Sudor Partners | Apparatus and method for the collection of analytes on a dermal patch |
| US5899856A (en) * | 1988-09-08 | 1999-05-04 | Sudormed, Inc. | Dermal patch detecting long-term alcohol consumption and method of use |
| US5096669A (en) * | 1988-09-15 | 1992-03-17 | I-Stat Corporation | Disposable sensing device for real time fluid analysis |
| US5112455A (en) * | 1990-07-20 | 1992-05-12 | I Stat Corporation | Method for analytically utilizing microfabricated sensors during wet-up |
| US5389954A (en) * | 1990-11-21 | 1995-02-14 | Canon Kabushiki Kaisha | Laser process apparatus for forming holes in a workpiece |
| US5330634A (en) * | 1992-08-28 | 1994-07-19 | Via Medical Corporation | Calibration solutions useful for analyses of biological fluids and methods employing same |
| JP2541081B2 (ja) * | 1992-08-28 | 1996-10-09 | 日本電気株式会社 | バイオセンサ及びバイオセンサの製造・使用方法 |
| GB9320850D0 (en) * | 1993-10-09 | 1993-12-01 | Terwee Thomas H M | Monitoring the concentration of a substance or a group of substances in a body fluid of a human or an animal |
| US5458140A (en) * | 1993-11-15 | 1995-10-17 | Non-Invasive Monitoring Company (Nimco) | Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers |
| US5885211A (en) * | 1993-11-15 | 1999-03-23 | Spectrix, Inc. | Microporation of human skin for monitoring the concentration of an analyte |
| DE4401400A1 (de) * | 1994-01-19 | 1995-07-20 | Ernst Prof Dr Pfeiffer | Verfahren und Anordnung zur kontinuierlichen Überwachung der Konzentration eines Metaboliten |
| EP0783727A4 (en) * | 1994-09-09 | 1998-01-14 | Univ Louisiana State | MICROSTRUCTURES AND METHOD FOR MANUFACTURING MICROSTRUCTURES |
| US5735273A (en) * | 1995-09-12 | 1998-04-07 | Cygnus, Inc. | Chemical signal-impermeable mask |
| DE69719761T2 (de) * | 1996-06-18 | 2003-12-18 | Alza Corp., Palo Alto | Vorrichtung zur verbesserung der transdermalen verabreichung von medikamenten oder der abnahme von körperflüssigkeiten |
| US6139718A (en) * | 1997-03-25 | 2000-10-31 | Cygnus, Inc. | Electrode with improved signal to noise ratio |
| US5747666A (en) * | 1997-03-26 | 1998-05-05 | Willis; John P. | Point-of-care analyzer module |
| US5928207A (en) * | 1997-06-30 | 1999-07-27 | The Regents Of The University Of California | Microneedle with isotropically etched tip, and method of fabricating such a device |
| SE9702739D0 (sv) * | 1997-07-17 | 1997-07-17 | Siemens Elema Ab | Förfarande för sköljning och kalibrering av sensor ingående i ett kroppsvätskeanalyssystem |
| US6223591B1 (en) * | 1997-11-28 | 2001-05-01 | Nikon Corporation | Probe needle arrangement and movement method for use in an atomic force microscope |
| DE69806963T2 (de) * | 1997-12-11 | 2002-11-21 | Alza Corp., Mountain View | Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses |
| US7066884B2 (en) * | 1998-01-08 | 2006-06-27 | Sontra Medical, Inc. | System, method, and device for non-invasive body fluid sampling and analysis |
| EP1045714A1 (en) * | 1998-01-08 | 2000-10-25 | Sontra Medical, L.P. | Sonophoretic enhanced transdermal transport |
| CA2265119C (en) * | 1998-03-13 | 2002-12-03 | Cygnus, Inc. | Biosensor, iontophoretic sampling system, and methods of use thereof |
| US6175752B1 (en) * | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
| CA2311487C (en) * | 1998-05-13 | 2004-02-10 | Cygnus, Inc. | Signal processing for measurement of physiological analytes |
| US7344499B1 (en) * | 1998-06-10 | 2008-03-18 | Georgia Tech Research Corporation | Microneedle device for extraction and sensing of bodily fluids |
| US6503231B1 (en) * | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
| US6602678B2 (en) * | 1998-09-04 | 2003-08-05 | Powderject Research Limited | Non- or minimally invasive monitoring methods |
| DE69913153D1 (de) * | 1998-09-17 | 2004-01-08 | Cygnus Therapeutic Systems | Gerät zum zusammendrücken einer gel/sensor-einheit |
| EP1064046A1 (en) * | 1999-04-22 | 2001-01-03 | Cygnus, Inc. | Methods and devices for removing interfering species |
| US6546268B1 (en) * | 1999-06-02 | 2003-04-08 | Ball Semiconductor, Inc. | Glucose sensor |
| US6743211B1 (en) * | 1999-11-23 | 2004-06-01 | Georgia Tech Research Corporation | Devices and methods for enhanced microneedle penetration of biological barriers |
| US6312612B1 (en) * | 1999-06-09 | 2001-11-06 | The Procter & Gamble Company | Apparatus and method for manufacturing an intracutaneous microneedle array |
| US6256533B1 (en) * | 1999-06-09 | 2001-07-03 | The Procter & Gamble Company | Apparatus and method for using an intracutaneous microneedle array |
| US6379324B1 (en) * | 1999-06-09 | 2002-04-30 | The Procter & Gamble Company | Intracutaneous microneedle array apparatus |
| US6406638B1 (en) * | 2000-01-06 | 2002-06-18 | The Regents Of The University Of California | Method of forming vertical, hollow needles within a semiconductor substrate, and needles formed thereby |
| US6558361B1 (en) * | 2000-03-09 | 2003-05-06 | Nanopass Ltd. | Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems |
| IL134997A0 (en) * | 2000-03-09 | 2001-05-20 | Yehoshua Yeshurun | Health care system based on micro device |
| WO2001088534A2 (en) * | 2000-05-16 | 2001-11-22 | Cygnus, Inc. | Methods for improving performance and reliability of biosensors |
| US6565532B1 (en) * | 2000-07-12 | 2003-05-20 | The Procter & Gamble Company | Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup |
| WO2002000278A2 (en) * | 2000-06-26 | 2002-01-03 | Microheart, Inc. | Method and apparatus for treating ischemic tissue |
| DE10038835B4 (de) * | 2000-08-04 | 2005-07-07 | Roche Diagnostics Gmbh | Mikrodialyseanordnung |
| US6533949B1 (en) * | 2000-08-28 | 2003-03-18 | Nanopass Ltd. | Microneedle structure and production method therefor |
| US7108681B2 (en) * | 2000-10-16 | 2006-09-19 | Corium International, Inc. | Microstructures for delivering a composition cutaneously to skin |
| US6638246B1 (en) * | 2000-11-28 | 2003-10-28 | Scimed Life Systems, Inc. | Medical device for delivery of a biologically active material to a lumen |
| EP1342075B1 (en) * | 2000-12-11 | 2008-09-10 | President And Fellows Of Harvard College | Device contaning nanosensors for detecting an analyte and its method of manufacture |
| GB0030929D0 (en) * | 2000-12-19 | 2001-01-31 | Inverness Medical Ltd | Analyte measurement |
| US20020099356A1 (en) * | 2001-01-19 | 2002-07-25 | Unger Evan C. | Transmembrane transport apparatus and method |
| US7041068B2 (en) * | 2001-06-12 | 2006-05-09 | Pelikan Technologies, Inc. | Sampling module device and method |
| US6875613B2 (en) * | 2001-06-12 | 2005-04-05 | Lifescan, Inc. | Biological fluid constituent sampling and measurement devices and methods |
| US6721586B2 (en) * | 2001-06-12 | 2004-04-13 | Lifescan, Inc. | Percutaneous biological fluid sampling and analyte measurement devices and methods |
| US6767341B2 (en) * | 2001-06-13 | 2004-07-27 | Abbott Laboratories | Microneedles for minimally invasive drug delivery |
| US6749792B2 (en) * | 2001-07-09 | 2004-06-15 | Lifescan, Inc. | Micro-needles and methods of manufacture and use thereof |
| US20030028087A1 (en) * | 2001-08-01 | 2003-02-06 | Yuzhakov Vadim Vladimirovich | Devices for analyte concentration determination and methods of using the same |
| US6881203B2 (en) * | 2001-09-05 | 2005-04-19 | 3M Innovative Properties Company | Microneedle arrays and methods of manufacturing the same |
| CA2500453A1 (en) * | 2001-09-28 | 2003-04-03 | Biovalve Technologies, Inc. | Microneedle with membrane |
| AU2002343457A1 (en) * | 2001-09-28 | 2003-04-07 | Biovalve Technologies, Inc. | Switchable microneedle arrays and systems and methods relating to same |
| US6689100B2 (en) * | 2001-10-05 | 2004-02-10 | Becton, Dickinson And Company | Microdevice and method of delivering or withdrawing a substance through the skin of an animal |
| US7399277B2 (en) * | 2001-12-27 | 2008-07-15 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
| US6908453B2 (en) * | 2002-01-15 | 2005-06-21 | 3M Innovative Properties Company | Microneedle devices and methods of manufacture |
| US20030143746A1 (en) * | 2002-01-31 | 2003-07-31 | Sage Burton H. | Self-calibrating body anayte monitoring system |
| US20030143113A2 (en) * | 2002-05-09 | 2003-07-31 | Lifescan, Inc. | Physiological sample collection devices and methods of using the same |
| EP1590034B1 (en) * | 2002-10-07 | 2014-05-14 | Biovalve Technologies, Inc. | Microneedle array patch |
| DK1575656T3 (da) * | 2002-10-11 | 2009-09-14 | Becton Dickinson Co | Insulinafgivesystem med sensor |
| US7415299B2 (en) * | 2003-04-18 | 2008-08-19 | The Regents Of The University Of California | Monitoring method and/or apparatus |
| US20060025717A1 (en) * | 2003-04-18 | 2006-02-02 | The Regents Of The University Of California | Method for forming hollow out-of-plane microneedles and devices formed hereby |
| US7524464B2 (en) * | 2003-09-26 | 2009-04-28 | Ahn Chong H | Smart disposable plastic lab-on-a-chip for point-of-care testing |
| DE602004028649D1 (de) * | 2003-11-13 | 2010-09-23 | Medtronic Minimed Inc | Langzeit-analytensensor-anordnung |
| US7118881B2 (en) * | 2003-12-05 | 2006-10-10 | Northwestern University | Micro/nano-fabricated glucose sensors using single-walled carbon nanotubes |
| US8147426B2 (en) * | 2003-12-31 | 2012-04-03 | Nipro Diagnostics, Inc. | Integrated diagnostic test system |
| US9414777B2 (en) * | 2004-07-13 | 2016-08-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US7076987B2 (en) * | 2004-08-05 | 2006-07-18 | Becton, Dickinson And Company | Method of producing tapered or pointed cannula |
| US20060058602A1 (en) * | 2004-08-17 | 2006-03-16 | Kwiatkowski Krzysztof C | Interstitial fluid analyzer |
| US7316665B2 (en) * | 2004-08-25 | 2008-01-08 | Becton, Dickinson And Company | Method and device for the delivery of a substance including a covering |
| US7627938B2 (en) * | 2004-10-15 | 2009-12-08 | Board Of Regents, The Univeristy Of Texas System | Tapered hollow metallic microneedle array assembly and method of making and using the same |
| US20060093658A1 (en) * | 2004-10-26 | 2006-05-04 | Gayatri Sathyan | Apparatus and method for transdermal delivery of desmopressin |
| US20070004989A1 (en) * | 2005-06-29 | 2007-01-04 | Parvinder Dhillon | Device for transdermal sampling |
| US20070038181A1 (en) * | 2005-08-09 | 2007-02-15 | Alexander Melamud | Method, system and device for delivering a substance to tissue |
| US20070066934A1 (en) * | 2005-09-19 | 2007-03-22 | Transport Pharmaceuticals, Inc. | Electrokinetic delivery system and methods therefor |
| US20080154107A1 (en) * | 2006-12-20 | 2008-06-26 | Jina Arvind N | Device, systems, methods and tools for continuous glucose monitoring |
| US20080058726A1 (en) * | 2006-08-30 | 2008-03-06 | Arvind Jina | Methods and Apparatus Incorporating a Surface Penetration Device |
| US7713196B2 (en) * | 2007-03-09 | 2010-05-11 | Nellcor Puritan Bennett Llc | Method for evaluating skin hydration and fluid compartmentalization |
-
2008
- 2008-11-20 US US12/275,145 patent/US20090131778A1/en not_active Abandoned
-
2009
- 2009-08-19 JP JP2011537444A patent/JP2012509138A/ja active Pending
- 2009-08-19 WO PCT/US2009/054338 patent/WO2010059276A1/en not_active Ceased
- 2009-08-19 EP EP09827918A patent/EP2355704A4/en not_active Withdrawn
- 2009-08-19 CA CA2743572A patent/CA2743572A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003038467A (ja) * | 2001-06-12 | 2003-02-12 | Lifescan Inc | 生物流体サンプリングおよび分析物測定の装置および方法 |
| US20060219576A1 (en) * | 2005-03-29 | 2006-10-05 | Jina Arvind N | Devices, Systems, Methods And Tools For Continuous Glucose Monitoring |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021506391A (ja) * | 2017-12-22 | 2021-02-22 | ブリテル アクチエボラグ パブリークBrighter Ab (Publ) | 診断用皮膚パッチ |
| JP2022537341A (ja) * | 2019-06-17 | 2022-08-25 | バイオリンク インコーポレイテッド | 分析物選択センサおよび注入システムの機械的結合 |
| JP7141625B1 (ja) | 2021-09-17 | 2022-09-26 | リンテック株式会社 | マイクロニードルパッチ及びマイクロニードル構造体 |
| WO2023042525A1 (ja) * | 2021-09-17 | 2023-03-23 | リンテック株式会社 | マイクロニードルパッチ |
| JP2023044484A (ja) * | 2021-09-17 | 2023-03-30 | リンテック株式会社 | マイクロニードルパッチ及びマイクロニードル構造体 |
| WO2024005192A1 (ja) * | 2022-06-30 | 2024-01-04 | コスメディ製薬株式会社 | グルコースセンサー用電極 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20090131778A1 (en) | 2009-05-21 |
| CA2743572A1 (en) | 2010-05-27 |
| EP2355704A4 (en) | 2013-04-03 |
| EP2355704A1 (en) | 2011-08-17 |
| WO2010059276A1 (en) | 2010-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012509138A (ja) | 持続的分析物モニタリングのためのデバイス、システム、方法、およびツール | |
| US8280476B2 (en) | Devices, systems, methods and tools for continuous glucose monitoring | |
| US20100049021A1 (en) | Devices, systems, methods and tools for continuous analyte monitoring | |
| US20080234562A1 (en) | Continuous analyte monitor with multi-point self-calibration | |
| US20080312518A1 (en) | On-demand analyte monitor and method of use | |
| US20080154107A1 (en) | Device, systems, methods and tools for continuous glucose monitoring | |
| US20090099427A1 (en) | Microneedle array with diverse needle configurations | |
| US6144869A (en) | Monitoring of physiological analytes | |
| US9028409B2 (en) | Fluid delivery with in vivo electrochemical analyte sensing | |
| EP2514362A1 (en) | Sensing fluid concentration for continuous glucose monitoring | |
| US20110257497A1 (en) | Flux Enhancement in Continuous Glucose Monitoring | |
| CN111929352B (zh) | 葡萄糖监测探头 | |
| US20170188898A1 (en) | Devices and methods for enhanced skin perforation for continuous glucose monitoring | |
| US20120172693A1 (en) | Pump Arrangement in Continuous Analyte Monitoring | |
| Hassan et al. | Perspectives on non-invasive glucose sensing using flexible hybrid-printed electronics systems | |
| WO2018226245A1 (en) | Devices and methods for enhanced skin perforation for continuous glucose monitoring |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120808 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120808 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131218 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20131220 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140515 |